Laurion Capital Management’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

Laurion Capital Management’s Portfolio NBRV Stock Details NBRV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-417	Closed	-$152K	–	1433
2018 Q4	$152K	Sell	417 -1,262	-75%	-$679K	﹤0.01%	991
2018 Q3	$1.13M	Buy	+1,679	New	+$1.19M	0.01%	662
2018 Q2	–	Sell	-227	Closed	-$285K	–	1694
2018 Q1	$285K	Sell	227 -502	-69%	-$742K	﹤0.01%	1145
2017 Q4	$1.09M	Sell	729 -1,641	-69%	-$2.59M	0.01%	948
2017 Q3	$4.85M	Buy	+2,370	New	+$5.56M	0.02%	519
2015 Q4	–	Sell	-107	Closed	-$255K	–	1124
2015 Q3	$255K	Buy	+107	New	+$284K	﹤0.01%	638

Other funds holding NBRV

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Laurion Capital Management's NBRV Position: Q1 2019 in Review

Laurion Capital Management sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q1 2019, closing a stake of 417 shares — an estimated $152K sold.

Laurion Capital Management first reported a position in NBRV in Q3 2015 and held it in 6 quarters. The position peaked at $4.85M in Q3 2017. 39 funds tracked by Wall St. Rank hold NBRV as of Q1 2019.

Laurion Capital Management reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q1 2019 after selling out during the quarter.
Laurion Capital Management sold 417 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q1 2019, an estimated $152K.
Laurion Capital Management first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q3 2015 and held it in 6 quarters.
Laurion Capital Management's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $4.85M in Q3 2017.
39 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q1 2019.

Based on Laurion Capital Management's 13F filing for Q1 2019, filed 8 May 2019.